3González-Duarte A, Cantu C, Ruiz-Sandoval JL, et al. Recurrent primary cerebral hemorrhage: frequency, mechanisms, and prognosis.Stroke, 1998,29(9): 1802-1805.
4Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology, 1998, 50(4): 961-965.
5Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology, 1998, 51 (3): 690-694.
6McCarron MO, Nicoll JA, Stewart J, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol, 1999, 58(7):711-718.
7McCarron MO, Nicoll JA, Ironside JW, et al. Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors. Stroke, 1999, 30(8): 1643-1646.
8Thomas T, Thomas G, McLendon C, et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature, 1996, 380(6570): 168-171.
9McCarron MO, Nicoll JA. Stewart J, et al. Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage. Neurology, 2000, 54(1 ): 242-244.
10Alonzo NC, Hyman BT, Rebeck GW, et al. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol, 1998, 57(4): 353-359.
